In a report released today, Lauren Lieberman from Barclays maintained a Buy rating on Keurig Dr Pepper (KDP – Research Report), with a price ...
Keurig Dr Pepper has booked fourth-quarter results that beat analyst estimates despite the US group recording a $718m ...
Analysts expect the Burlington, Massachusetts-based company to report quarterly earnings at 57 cents per share, up from 55 ...
Beverage maker Keurig Dr Pepper said it "capitalized" on the dirty soda's popularity with the help of social media in Q4.
Lauren Lieberman from Barclays sets a price target of $36 for NASDAQ:KDP, indicating a potential upside of 5.51%. Q4 2024 ...
Piper Sandler started coverage on Keurig Dr Pepper in a report on Tuesday, January 7th. They issued a “neutral” rating and a $35.00 price objective for the company. Finally, Barclays cut their ...
On Jan. 17, Barclays PLC (BCS) reduced its price target for Keurig Dr Pepper to $36 from $39, while maintaining an “Overweight” rating on the stock. The analyst noted, "It feels like there ...
Gary Posternack, Barclays The longtime global M&A leader ... with consumer and retail firms such as Campbell's and Keurig Dr Pepper. He started his career with Goldman Sachs in the 1990s and ...
In a report released today, Michael Lavery from Piper Sandler maintained a Hold rating on Keurig Dr Pepper (KDP – Research Report), with a ...